Background: Periodontitis is recognized as one of the most prevalent oral dysbiotic inflammatory diseases, ultimately leading to the irreversible destruction of periodontal tissues. Macrophages play a pivotal role in the development and progression of periodontitis, and the feasibility of targeting them therapeutically has been established. Since metabolic switching significantly contributes to macrophage regulation, conducting an in-depth review of macrophage metabolism in periodontitis may serve as the foundation for developing innovative treatments. Summary: This paper has been carefully reviewed to provide a comprehensive overview of the roles played by macrophages in periodontitis and associated comorbidities. Initially, detailed presentations on the metabolic reprogramming of macrophages, including glucose, lipid, and amino acid metabolism, were provided. Subsequently, dominating macrophage phenotype and metabolism under lipopolysaccharide (LPS) stimulation or during periodontitis were presented with emphasize on critical molecules involved. Furthermore, in recognition of the close association between periodontitis and several comorbidities, the interaction among macrophage metabolism, periodontitis, and related metabolic diseases, was thoroughly discussed. Key Messages: Through the examination of current research on macrophage metabolic reprogramming induced by periodontitis, this review provides potential immunometabolic therapeutic targets for the future and raises many important, yet unstudied, subjects for follow-up.

Periodontitis is characterized by the formation of periodontal pockets and subsequent alveolar bone loss due to plaque biofilm dysbiosis [1, 2]. It is associated with various chronic systemic diseases, including diabetes, obesity, respiratory diseases, osteoporosis, cardiovascular disease, and Alzheimer’s disease [3‒7]. Understanding the mechanism of periodontitis is crucial for developing advanced treatment approaches, particularly as it remains a significant global health issue despite existing therapeutic options.

Macrophages are essential components of the innate immune response and serve as precursors to osteoclastic lineages. Excessive accumulation and activation of macrophages can lead to dysregulated inflammatory responses and tissue injury. Research indicates that periodontal tissue destruction in periodontitis is largely attributed to the host immune response to infection [8], with emerging evidence linking the enrichment of inflammatory macrophages, especially M1 macrophages, to overactive osteoclastogenesis during periodontitis. Therefore, targeting macrophage function in the periodontium may be promising for preventing and treating periodontitis and its complications.

Metabolic reprogramming regulates macrophage activation and function, and targeting macrophage metabolism has shown promise in treating orthopedic diseases. For instance, d-mannose stimulates macrophage lipid metabolism, mitigating calvarial osteolysis induced by lipopolysaccharide (LPS) [9]. Additionally, the inhibitor 2-deoxy-glucose (2-DG), which blocks glucose uptake and glycolysis, can alleviate arthritic symptoms in adjuvant arthritis rats through the restoration of M1/M2 polarization [10]. Therefore, an in-depth study of macrophage metabolic reprogramming in periodontitis may offer new insights into its treatment.

This review starts by examining the role of macrophages in periodontitis and their potential as therapeutic targets. Given the rapid growth of the field of immunometabolism, it explores how altered macrophage glucose, lipid, and amino acid metabolism contribute to periodontitis by regulating macrophage function and key regulators in the process. Lastly, given the strong association between periodontitis and systemic diseases, the bidirectional relationships between dysregulated macrophage metabolism and comorbidities such as obesity, diabetes, and atherosclerosis are discussed. These comorbidities may arise from perturbed macrophage functions due to periodontitis, and reciprocally, exacerbate periodontitis by promoting unfavorable macrophage metabolism. In conclusion, the current landscape of immunometabolism in periodontitis is discussed, presenting potential avenues for future research in this area.

Situated at the periodontal interface between the host and the external environment, macrophages collaborate with other innate immune cells to form the first line of host defense against invading pathogens. However, their hyperactivation can lead to tissue destruction and exacerbate periodontitis.

Chemotaxis of Macrophages in Periodontitis

Macrophages are classified into two categories based on their locations: resident macrophages and circulating macrophages. Circulating macrophages, which originate from monocytes in the blood, are recruited to inflammatory sites, including those affected by periodontitis, in response to the release of cytokines and chemokines. As for the resident macrophages, invasion by periodontal microbes prompts them to produce monocyte chemoattractant protein-1, recruiting more macrophages to the periodontal tissue. Additionally, macrophages secrete chemotactic cytokines, such as interleukin 8 (IL-8), which drive polymorphonuclear neutrophil infiltration at inflammatory periodontal sites [11]. The chemotaxis of macrophages increases their presence in the inflammatory microenvironment, facilitating their subsequent functions.

Macrophage Polarizations in Periodontitis

Macrophages exhibit different polarizations in response to complex signals in the microenvironment, broadly classified as proinflammatory (M1) and anti-inflammatory (M2) [12‒14] (shown in Fig. 1). Although various macrophage phenotypes have been identified through single-cell analysis, studies have yet to explore the relationship between these phenotypes and macrophage metabolism [15, 16]. Consequently, this review primarily focuses on the metabolic characteristics of M1 and M2 macrophages. M1 macrophages eliminate pathogens through phagocytosis and produce proinflammatory cytokines [17], while M2 macrophages primarily aim at resolving inflammation and tissue repair [18, 19]. M1 macrophages release prostaglandin E2, tumor necrosis factor-alpha (TNF-α), IL-1β, IL-6, and IL-12 in the bone destruction site [20], promoting osteoclast activity [21]. In contrast, M2 macrophages counteract the response of M1 by producing IL-4, IL-10, IL-13, transforming growth factor-beta, and chemokines like C-C motif chemokine ligand 17 (CCL17) and CCL22, as well as the enzyme arginase 1 (ARG1), functioning in reducing inflammation and tissue repair [22, 23].

Fig. 1.

Different metabolic reaction of M1 and M2 macrophages in periodontitis. The left half of the figure displays that after LPS of bacterial stimulation, macrophages polarize toward M1 due to metabolic pattern changes, thus inducing osteoclastogenesis and further aggravating bone loss. The right half of the figure illustrates the metabolism of M2 macrophages, exhibiting that M2 macrophages are inhibiting factors of periodontitis.

Fig. 1.

Different metabolic reaction of M1 and M2 macrophages in periodontitis. The left half of the figure displays that after LPS of bacterial stimulation, macrophages polarize toward M1 due to metabolic pattern changes, thus inducing osteoclastogenesis and further aggravating bone loss. The right half of the figure illustrates the metabolism of M2 macrophages, exhibiting that M2 macrophages are inhibiting factors of periodontitis.

Close modal

During the development of inflammation, the existence of M1 and M2 is in a dynamic equilibrium. Periodontitis can be divided into active and static stages according to histopathological manifestations. The active stage is associated with the infiltration and activation of M1, leading to bone loss, while the static stage possesses a larger proportion of M2 and repair damaged tissue [24]. The phenotype of macrophages can be switched from M2 to M1 during some stages of periodontitis, thus aggravating periodontal tissue injury [24]. In periodontitis, M1 polarization can be induced by LPS, expressed on the outer membrane of Porphyromonas gingivalis, and binds to CD14 to activate Toll-like receptor 2 (TLR2) and TLR4 in macrophages [5]. Moreover, in diabetes mellitus (DM)-periodontitis, M1 polarization is enhanced compared to normal periodontitis, and elevated IL-1β and reactive oxygen species (ROS) production are the induction of M1 polarization [25, 26]. Both LPS and IL-1β promote the activation and differentiation of osteoclasts, leading to periodontal bone resorption [27]. Therefore, the extent of M1 polarization differs according to the periodontal microenvironment and subsequently influences the severity of alveolar bone destruction. Similarly, M2 polarization can be increased during periodontitis under specific conditions. Inflammatory factors, like TNF-α, can uplift the expression of CD73 and WNT5A/RUNKL/OPG system through the exosome of gingival tissue-derived mesenchymal stem cells, thus inducing M2 polarization and inhibiting periodontal bone loss [28]. Moreover, exogenous IL-37, CCL2, and the hypoxia-inducible factor-1α activator dimethyloxalylglycine are capable to increase the number of M2 phenotype macrophages and downregulate TNF-α, IL-6, CD86, and monocyte chemoattractant protein-1 expression in vitro, relieving the bone loss in periodontitis [29‒31]. These findings on promoting M2 polarization may provide an effective approach to periodontitis treatment.

Phagocytosis and Efferocytosis of Macrophages in Periodontitis

Macrophage phagocytosis refers to the process by which macrophages engulf and digest foreign particles, microorganisms, cellular debris, and apoptotic cells as part of the body’s immune response. During periodontitis, the phagocytic ability, particularly of M1 macrophages, is enhanced [32]. Macrophages’ phagocytosis relies on the expression of various pattern recognition receptors on the outer membrane, such as TLR2 or TLR4, to recognize LPS [33]. The efficiency of phagocytosis is regulated by molecules within macrophages. M2 macrophages secrete specialized pro-resolving mediators, a vital family of molecules involved in inflammation regression in periodontium [34], and some of specialized pro-resolving mediators, such as resolution E1 (RvE1), to enhance macrophage phagocytosis and promote periodontal regeneration [35, 36].

Efferocytosis is a multistep process that macrophages phagocytose apoptotic cells [37], and it helps maintain the homeostasis of tissues, since apoptotic cells release many harmful substances if not engulfed promptly [38]. In periodontal tissue, an increased number of apoptotic neutrophils, along with the release of neutrophil extracellular traps and reduced macrophage efferocytosis, resulted in prolonged inflammation [39]. Some molecules, like developmental endothelial locus-1 (Del-1), exert anti-inflammatory effects on periodontitis in mice via facilitating efferocytosis, presenting a potential therapeutic direction [37, 40, 41].

Immune Cross-Talk of Macrophages in Periodontitis

There are intricate communications and interactions among macrophages and other immune cells within the periodontal tissue during the inflammatory process. Macrophages closely interact with T helper cells (Th). On the one hand, M1 macrophages induce Th1 and Th17 responses through IL-12 and IL-23, respectively, leading to more severe bone resorption [8, 29]. In contrast, M2 macrophages produce IL-4 and transforming growth factor-beta, inducing Th2 and Treg cell responses, which attenuates gingival inflammation [42, 43]. On the other hand, Th1 lymphocytes secrete interferon-gamma and activate neutrophils and macrophages, intensifying the gingival inflammation [44, 45]. Th2 cells feature in producing IL-4, promoting M2 polarization [46]. For the receptor-ligand interaction, Agrafioti et al. [15] found that PVR-TIGIT, PVR-CD96, and PV-CD226 receptor/ligand pairs interact between M1 and T cells, while TNF-NOTCH1 and PVR-TNFSF9 receptor/ligand pairs interact between M1 and B cells, and many other cross-talks were enhanced in periodontitis-affected sites. Moreover, B cell also interacts with macrophages. Dendritic cells or macrophages produce B-cell activating factor, whose knockdown suppresses TNF-α expression and M1 polarization, reducing the bone loss in periodontitis [47, 48]. Coculturing B cells from mice infected with Tannerella forsythia with macrophage induces the formation of multinucleated osteoclasts via the RANKL-RANK interaction [49]. Therefore, the relationship between macrophages and other immune cells during periodontitis deserves attention.

To conclude, macrophages play a complex role during periodontitis, encompassing cell accumulation, polarization, phagocytosis and efferocytosis, cytokine production, and interaction with other immune cells. During the active stage of periodontitis, or under some systematic diseases like diabetes, M1 possesses a larger proportion in periodontal tissue and accelerates bone resorption, while M2 plays a vital role in the static stage, facilitating inflammation regression. Therefore, methods to inhibit M1 polarization, promote M2 polarization, and maintain periodontitis in a static stage are worth further exploration.

In recent years, research on the dynamic modulation of cellular metabolism in macrophages in response to the microenvironment has flourished, highlighting its crucial role in regulating macrophage activation, function, and biology [50‒52]. The focus has primarily centered on the three major metabolic pathways in macrophages (shown in Fig. 2), which are valuable for determining phenotypes.

Fig. 2.

Overview of glucose, lipid, and amino acid metabolism of macrophages. PPP, pentose phosphate pathway; TG, triglyceride; TCA, tricarboxylic acid cycle.

Fig. 2.

Overview of glucose, lipid, and amino acid metabolism of macrophages. PPP, pentose phosphate pathway; TG, triglyceride; TCA, tricarboxylic acid cycle.

Close modal

Glucose Metabolism of Macrophage

Glucose metabolism, the primary mechanism to generate adenosine triphosphate (ATP), has rapidly become a crucial subject due to its modulation on macrophage activation state and function [53]. The two distinct modes of the tricarboxylic acid (TCA) cycle, activated by different stimuli, significantly contribute to these processes. Upon stimulation with LPS/interferon-gamma, macrophages undergo a metabolic shift characterized by suppressed oxidative phosphorylation (OXPHOS), heightened glycolysis, and the accumulation of succinate and itaconate, in stark contrast to IL-4-stimulated macrophages, which maintain full TCA cycle and OXPHOS functionality [54‒57]. Despite the inefficiency of the glycolysis pathway in producing ATP, its intermediates can be utilized as substrates in various other metabolic pathways [58]. Glucose utilization through the pentose phosphate pathway plays a dominant role in generating nicotinamide adenine dinucleotide phosphate hydrogen, providing the necessary redox power to produce reduced glutathione. This is crucial for maintaining macrophage functions, such as managing ROS and providing antioxidant protection [59].

Research has shown that polarized macrophage phenotypes, M1 and M2, are defined by unique glucose metabolic pathways: glycolysis for M1 and oxidative phosphorylation for M2 macrophages [60, 61]. These metabolic differences may be attributed to the distinct functionalities of M1 and M2 macrophages. M1 macrophages mainly function in innate immune response to infection. To meet the specific requirements of rapid bactericidal activity in a typical hypoxic inflammatory environment, anaerobic glycolysis suits the energy needs of macrophages. M2 macrophages, essential for tissue remodeling and repair, rely on an intact TCA cycle and an enhanced mitochondrial OXPHOS for sustainable intracellular energy supply.

Reprogramming macrophage glucose metabolism not only initiates the inflammatory response but also represents a potential therapeutic target for inflammatory diseases. 2-DG, a competitive hexokinase inhibitor that blocks glucose uptake and glycolysis, has been found to suppress LPS-induced IL-1β in M1 macrophages by downregulating the levels of the TCA cycle intermediate succinate [62].

Glucose Metabolism of Macrophage in Periodontitis

Studies concerning the periodontitis-related metabolic reprogramming in macrophages adopt both LPS and viable bacteria as the external stimuli [63, 64]. Multiple pathogenic bacteria, including P. gingivalis, Fusobacterium nucleatum, Treponema denticola, and T. forsythia, participate in the development of periodontitis [65, 66]. In periodontitis, activated macrophages undergo metabolic switching from a resting to an active state to generate a large amount of ATP and macromolecules needed for their effector functions. It has been demonstrated in vitro that viable P. gingivalis leads to a metabolic shift toward glycolysis in macrophages, characterized by a reduction in OXPHOS, mitochondrial function, and the expression of regulatory genes in the TCA cycle [67]. The switch from OXPHOS to glycolysis activates proinflammatory macrophages [62, 68, 69], enhancing the clearance of intracellular pathogens, which are crucial factors in promoting periodontitis through immune invasion and tissue destruction [70, 71], by rapid ATP generation and production nitric oxide (NO) and ROS [72, 73]. Interestingly, once the switch to glycolysis occurs, these activated macrophages are unable to repolarize to the anti-inflammatory type, primarily due to mitochondrial dysfunction, particularly the inhibition of OXPHOS [73]. Therefore, metabolic reprogramming aimed at restoring mitochondrial function and OXPHOS could be a potential strategy for controlling periodontitis.

We also comprehensively discussed the function of two glycolytic enzymes, pyruvate kinase M2 (PKM2) and glucose transporter type 1 (GLUT1), which bridge metabolic and inflammatory dysfunction in periodontitis. In glycolysis, pyruvate kinase catalyzes the last step, converting glucose to pyruvate along with the production of ATP and nicotinamide adenine dinucleotide. PKM2 is expressed in proliferating cells, such as leukocytes, and is one of the four isoforms of pyruvate kinase [74]. PKM2 has been discovered in the gingival crevicular fluid (GCF) of healthy people and in the GCF and saliva of patients with periodontitis and gingivitis [74]. It has been shown that PKM2 increases in the GCF from dogs with gingivitis progressing to the early-stage periodontitis [75]. Similarly, another study found a higher value of PKM2 in the saliva of periodontitis donors [76]. Upon LPS stimulation, PKM2 expression in macrophages is upregulated, and the translocation of PKM2 to the nucleus generates a complex formation with transcription factor “hypoxia-inducible factor-1α” to activate multiple gene transcriptions, such as IL-1β [77], IL-6 [78], and high-mobility group box-1 protein (HMGB1) [79]. Inhibition or knockdown of PKM2 restricts the release of these mediators induced by LPS. The association between GLUT1-modulated glucose flux in macrophages and periodontitis is elucidated in the latter section on Macrophage dysfunction and metabolic syndrome related to periodontitis.

Lipid Metabolism of Macrophages

Recent findings have shown that lipid synthesis is of value in the modulation of macrophage functions. Acetyl-coenzyme A (acetyl-CoA) acts as a key building block for the synthesis of cholesterol, isoprenoids, and fatty acids (FAs), while FAs are utilized for the production of triglycerides and complex lipids [80]. In M1 macrophages, lipid biosynthesis is crucial for membrane remodeling and the synthesis of inflammatory mediators. To meet these requirements, glycolysis is upregulated to ensure ATP generation and fuels the TCA cycle, securing the supply of acetyl-CoA from citrate [81].

In contrast, OXPHOS in M2 macrophages is sustained by the uptake of FAs [82], which are subsequently oxidized through fatty acid oxidation (FAO). The process of FA uptake occurs through the lipolysis of circulating lipoproteins [83] and direct absorption of free FAs [55]. The acquisition of exogenous FAs in macrophages is mostly dependent on lipoprotein lipase, which hydrolyzes triglycerides into free FAs. Lipoprotein lipase activity is substantially higher in M2 macrophages in anti-infective treatment, resulting in increased FA uptake, whereas this pathway is inhibited in M1 macrophages [84, 85].

Lipid Metabolism of Macrophages in Periodontitis

Upon the stimulation of LPS, macrophages initiate the de novo lipogenesis process by oxidizing glucose to produce a cytosolic pool of citrate that later becomes acetyl-CoA, the essential component of FA [86]. Additionally, LPS stimulation also promotes FA synthesis through the facilitation of pentose phosphate pathway in glycolysis, where the essential reducing power, nicotinamide adenine dinucleotide phosphate hydrogen, is generated [87]. Furthermore, FAs combined with glycerol 3-phosphate, another product out of glucose, can be esterified into triglycerides. In summary, upon microbial stimulation, macrophages convert the enhanced glucose metabolism to de novo lipogenesis and triglyceride synthesis.

The local inflammatory response in periodontal tissue can convert low-density lipoprotein into oxidized low-density lipoprotein (OxLDL) through free radical oxidation. Previous research has also verified the presence of OxLDL in the gingival crevicular fluid [88]. It has been shown that OxLDL can be taken up by macrophages via scavenger receptors [89]. However, the effects of OxLDL treatment on macrophage activation vary across studies. While some research indicates no significant changes, other studies have observed either proinflammatory or anti-inflammatory effects of OxLDL treatment [90]. The impact of OxLDL loading on macrophages in the context of periodontitis remains to be explored in future research.

Amino Acid Metabolism of Macrophages

Experimental evidence has shown that the modulation of macrophage activation is significantly influenced by amino acid metabolism, particularly through the utilization of arginine and glutamine.

Arginine Metabolism

Arginine is an essential basic amino acid that regulates macrophage activation through two enzymes: inducible nitric oxide synthase (iNOS) and ARG1. Highly expressed in M1 macrophages, iNOS recognizes arginine as a substrate to generate NO and citrulline using oxygen. Citrulline is catalyzed by argininosuccinate synthase and argininosuccinate lyase to generate arginine and release NO via the urea cycle, forming the citrulline-NO cycle. M2 macrophages produce ARG1, an enzyme that breaks down arginine into ornithine and urea, thereby suppressing the production of NO [91]. In general, ARG1 restrains the inflammatory response of macrophages, whereas iNOS promotes the inflammatory response.

Glutamine Metabolism

Through its involvement in the TCA cycle, glutamine plays a crucial role in polarizing macrophages into M1 and M2. The glutamine synthetase 1 converts imported glutamine into glutamate, which is then converted into α-ketoglutarate (α-KG). α-KG enters the TCA cycle to support OXPHOS and promote M2 macrophage polarization [54]. A low α-KG/succinic acid ratio enhances M1 macrophage activation and a high α-KG/succinic acid ratio promotes the polarization of M2-type macrophages [60]. Compared to M1 macrophages, glutamine metabolism is significantly increased in M2 macrophages. Furthermore, previous studies have shown that α-KG can promote macrophage polarization to M2 type by regulating FAO and epigenetic pathways [54].

Amino Acid Metabolism of Macrophages in Periodontitis

Despite the lack of direct literature reports on the relationship between macrophage amino acid metabolism and periodontitis, a study found that the use of l-ornithine, a product of arginine metabolism, in conjunction with scaling and root planning treatment for periodontitis provides additional immunological benefits. This treatment was found to increase the CD163+ M2 macrophage subpopulation in the gingiva affected by periodontitis [92]. Besides, LPS increases the expression of argininosuccinate synthase and argininosuccinate lyase in mouse macrophages, leading to heightened arginine and NO synthesis [93], while LPS-stimulated M1-type macrophage polarization is less dependent on glutamine metabolism [54]. Given the importance of amino acid metabolism in macrophage polarization, it can be extrapolated that targeting this aspect holds great promise for treating periodontitis.

Impact of Metabolic Diseases on Periodontitis through Macrophage Metabolism

Extensive literature has explored the association between metabolic dysregulation and periodontitis. During infection, macrophages typically polarize to the M1 phenotype to initiate host immune response and later polarize to the M2 phenotype to dampen proinflammatory responses for the repair of damaged tissues. Disruption of phenotypic switch in macrophages, dysregulation of M1 activation, and prolonged restriction of M2 activation are associated with various diseases [94‒96]. In general, periodontal treatment should alleviate the inflammatory response and restore lost tissue structure and function. Nevertheless, conventional treatments, such as mechanical plaque removal and guided tissue regeneration, have demonstrated limited effectiveness in patients with systemic diseases [97, 98]. Tissue-resident macrophages are key players in both periodontitis and these metabolic diseases; therefore, a better understanding of macrophage metabolism may provide new insights to the treatment of periodontitis with comorbidities.

Impact of Obesity on Periodontitis through Macrophage Metabolism

Obesity is a significant risk factor for periodontal inflammation, second only to smoking [99], with growing evidence confirming its potential to exacerbate the progression of periodontitis and associated inflammation [100‒103]. This phenomenon may be explained by a blunted immune response in obese individuals to periodontal infections, referred to as immune tolerance [104]. A high-fat diet can cause gut flora imbalance, which facilitates the permeation of LPS through the gut mucosa and its entry into the bloodstream [105], leading to higher serum LPS levels in obese individuals [106]. Furthermore, in obese individuals, macrophages are frequently exposed to chronic, low-grade inflammatory signals such as free FAs. As a result, they develop immune tolerance, which diminishes their inflammatory response to subsequent infections caused by P. gingivalis or its components [104, 107, 108]. Interestingly, a blunted macrophage response is associated with increased arginase/iNOS ratios, which inhibits M1 polarization [109]. In the diet-induced obesity model, inhibition of arginase may allow macrophages to regain their active inflammatory functions when M1 macrophages were activated [19, 109]. Taken together, the detrimental effects of overweight/obesity on periodontal inflammation may be the consequence of disruption of M1 macrophage polarization due to biased arginine metabolism. However, another study has yielded incongruent results regarding the influence of high-fat diet on the immune response of macrophages in periodontitis, showing that high-fat diet increases the inflammatory response of macrophages to P. gingivalis infection [100].

Furthermore, various factors associated with obesity, including free FAs, cholesterol, and LPS, affect glucose-6-phosphate dehydrogenase in macrophages – an enzyme crucial for the pentose phosphate pathway [110]. Upregulation of glucose-6-phosphate dehydrogenase is also related to heightened glucose metabolism via the pentose phosphate pathway and redox regulation [111]. Its upregulation in obesity could potentially enhance glucose metabolism, making obese people more susceptible to hyperglycemia (HG). The adverse effects of HG on periodontitis will be discussed in the next section.

Impact of Diabetes on Periodontitis through Macrophage Metabolism

DM is an emerging and widely acknowledged systemic risk factor affecting periodontal health. HG induces chronic low-grade inflammation, which has recently been identified as a contributor to diabetes-related tissue damage, including inflammatory bone loss in periodontitis. When macrophages are exposed to high-glucose conditions, their polarization shifts toward M1 phenotype [112]. As previously mentioned, M1 macrophages’ glucose metabolism is characterized by glycolysis, which can activate the NOD-like receptor family pyrin domain-containing protein 3 (NLRP3) inflammasome in macrophages via ROS signaling [113], promoting the secretion of acute and long-term secretion of TNF-α and IL-1β [112]. Elevated glucose levels, in combination with P. gingivalis – LPS, have been found to further enhance macrophage mitochondrial dehydrogenase activity, a crucial enzyme in glycolysis, and the secretion of proinflammatory cytokines IL-6, TNF-α, and prostaglandin E2 [114]. Compared to patients with chronic periodontitis alone, the GCF of patients with both DM and chronic periodontitis contains higher levels of proinflammatory cytokines [115]. Under hyperglycemic conditions, macrophages exhibit increased glucose metabolism through the upregulation of GLUT1 expression. GLUT1 is a membrane transporter that plays a critical role in the glucose uptake by macrophage. Though several GLUT-family members are expressed on macrophages, GLUT1 remains indispensable for glucose uptake. The selective GLUT1 ablation compromises glucose entry, resulting in decreased metabolite content for glycolysis and pentose phosphate pathway [116]. However, the release of inflammatory cytokines is not significantly affected by GLUT1 ablation [116], making its impact on periodontitis uncertain and in need of further validation. To sum up, HG in diabetes induces macrophage inflammation and accelerates periodontal damage through increased glycolysis, but the key regulatory factors remain unclear.

Impact of Periodontitis on Systemic Diseases through Macrophage Metabolism

Periodontitis has been associated with a number of systemic diseases [117‒120]. The systemic inflammation caused by periodontitis can result from inflammatory substances overflowing from affected tissues or from periodontal pathogens entering the bloodstream, which is facilitated by the ulceration of periodontal pockets [7, 121, 122]. Though the correlation between periodontitis and systemic diseases has been shown to be significant, the underlying molecular mechanisms have not yet been sufficiently studied. As one of the most well-studied immune cells in periodontitis, macrophages may form part of the communication network bridging periodontitis and systemic diseases. Pathogens related to periodontitis act directly upon local macrophages in periodontal tissue, while circulating periodontal pathogens can migrate to other tissues and affect their resident macrophages. Consequently, macrophage activation and the subsequent cellular responses to periodontal pathogen are topics of pivotal importance for uncovering the molecular mechanisms of systemic diseases induced by periodontitis.

Impact of Periodontitis on Atherosclerosis through Macrophage Metabolism

Ample evidence supports a causal relationship between periodontal infection and cardiovascular diseases. Multiple periodontal pathogens have been identified in atheromatous plaques surgically removed from patients with atherosclerosis, including P. gingivalis, F. nucleatum, T. denticola, and T. forsythia [123, 124].

Foam cells, derived from macrophages abundant in cholesteryl esters, are a typical feature of atherosclerotic plaques [125]. To prevent foam cell formation, it is vital to maintain macrophage cholesterol homeostasis, which depends on the balance among cholesterol synthesis, influx, and efflux. LPS appears to be a critical link bridging periodontitis and the development of atherosclerosis. The underlying mechanisms involve dysregulated cholesterol homeostasis, with excess cholesterol ester generation by acyl-coenzyme A acyltransferase 1 (ACAT1) and decreased cellular cholesterol efflux mediated by ATP-binding cassette transporter G1 (ABCG1) [126]. A notable feature of chronic periodontitis is multiple but transient episodes of bacteremia, which promote the spread of LPS from the periodontium to atherosclerotic plaques, ultimately contributing to foam cell formation [126]. Stimulation by viable bacteria has yielded the same results as LPS. In the presence of LDL, macrophages infected with P. gingivalis initiate foam cell formation in a dose-dependent manner, accompanied by the induction of LDL oxidation, likely a key step in atherosclerosis [127]. Besides, alterations in Ca2+ and ROS signaling induced by periodontal pathogens play a pivotal role in the dysregulation of lipid homeostasis, ultimately leading to the transformation of macrophages into foam cells [128].

In addition, F. nucleatum is closely associated with atherosclerosis. Studies have revealed that mice infected with F. nucleatum through oral gavage exhibit aortic tissue defects and more severe atherosclerotic lesions, characterized by subcutaneous macrophage infiltration, M1 polarization, and lipid deposition [129]. Moreover, F. nucleatum regulates the expression of lipid metabolism-related genes (ACAT1, ABCA1, and ABCG1), thereby promoting OxLDL-induced cholesterol phagocytosis and accumulation [129]. Additionally, PI3K-AKT/MAPK/NF-κB signaling pathways have been shown to be related to macrophage activated by F. nucleatum, resulting in facilitated gingival inflammation, reduced lipid intake, and increased lipid deposition [130].

Impact of Periodontitis on Diabetes through Macrophage Metabolism

A noteworthy point is the existence of a quantitative relationship between the surface area of inflamed periodontal tissue and the glycosylated hemoglobin level. Explicitly, every 333 mm2 increase in the inflamed epithelial area of periodontal pocket is associated with a 1% increase in hemoglobin in patients with periodontitis and type 2 diabetes [131]. The theory that periodontitis exacerbates diabetes through macrophage metabolism is supported by the integration of several lines of evidence. Macrophages highly express FA binding protein 4 (FABP4), a member of the FABP family [132]. As a lipid-binding chaperone, FABP4 regulates the uptake, release, and storage of FA through reversible binding with high affinity to saturated and unsaturated long-chain FAs, thereby promoting the progression of multiple systemic diseases such as obesity and type 2 diabetes [133‒135]. Consequently, FABP4 plays a central, critical role in connecting lipid metabolism to innate immunity functions and inflammation [133]. Infection with P. gingivalis or F. nucleatum can significantly elevate the expression of FABP4 on macrophages, resulting in enhanced lipid uptake [136]. Conversely, FABP4 blood level could be lowered in response to periodontitis treatment [137]. Available evidence shows the correlation between FABP4 and periodontitis and the potential contribution of periodontitis to the progression of diabetes through macrophage lipid metabolism.

Impact of Periodontitis on Obesity through Macrophage Metabolism

Several studies have explored the mechanisms behind the unfavorable impact of periodontitis on obesity, primarily focusing on the increase in systemic inflammatory biomarkers, as periodontal pathogens and their by-products may enter the circulation and affect systemic health. Compared to healthy individuals, patients with periodontitis exhibit higher blood levels of C-reactive protein, IL-1, and IL-6 [122, 138]. Adipose tissue macrophages (ATMs) are vital for adipose tissue function. However, their inflammatory polarization in obesity exacerbates tissue dysfunction, characterized by increased infiltration and activation of ATMs in white adipose tissue due to cytokine influence [139, 140]. Emerging evidence indicates that elevated glycolysis, cholesterol accumulation, and decreased FAO contribute to the M1 proinflammatory polarization of ATMs [141]. Nevertheless, no published data currently exist to confirm the hypothesized connection between elevated circulating cytokines due to periodontitis and ATM metabolism, posing an area of future work.

Impact of Periodontitis on Rheumatoid Arthritis through Macrophage Metabolism

Rheumatoid arthritis (RA) is one of the most common diseases characterized by chronic inflammation and bone destruction. The pathogenesis of RA includes the influx of macrophages, whose numbers is positively related with RA activity [142]. M1 macrophages are dominant in the RA synovium, exhibiting a metabolic profile characterized by high expression of the glycolytic enzyme glutathione, as well as COX‐2 and elevated activity of iNOS2 [143, 144]. P. gingivalis from the periodontium can spread through the bloodstream, and its DNA has been detected in the synovial fluid of RA patients [145]. P. gingivalis also possesses a unique microbial enzyme, peptidylarginine deiminase (PAD), which mediates the onset of RA [146]. In periodontitis, apoptosis in macrophages can lead to the leakage of intracellular PAD into the extracellular environment, activating human PAD and exacerbating RA [147]. Moreover, LPS produced by P. gingivalis enhances the levels of glycolysis and accumulates intermediate metabolites of the TCA cycle, especially succinic acid in macrophages [148, 149]. Succinic acid has been found to be upregulated in the synovial fluid of RA patients and can induce the production of IL-1β [143, 149]. All these studies demonstrate that macrophages, as the first responder to invading pathogens, are influenced by P. gingivalis and may be partially responsible for RA.

Current studies on macrophage metabolism and periodontitis primarily focus on macrophage polarization and cytokine/chemokine secretion. The potential link between macrophage metabolism and the regulation of monocyte migration and local proliferation presents a significant area for further investigation, as the number of circulating leukocytes is closely related to periodontitis [150] and comorbidities such as atherosclerosis [59]. In summary, M1 macrophages rely on glycolysis, lipogenesis, and iNOS activity, whereas M2 macrophages depend on OXPHOS, FAO, ARG1 activity, and reduced iNOS activity. Identifying strategies to manipulate these metabolic pathways to reverse macrophage proinflammatory polarization could offer new treatments for periodontitis. Potential targets in macrophage glucose metabolism include 2-DG, PKM2, and GLUT1. However, further validation is needed for the roles of regulators in OXPHOS, lipid, and amino acid metabolism in periodontitis therapy.

Macrophages are pivotal in the interplay between periodontitis and metabolic conditions, driving inflammation and disease progression. Metabolic diseases such as obesity and diabetes alter macrophage metabolism, worsening inflammation and tissue damage in periodontitis. Furthermore, periodontitis can exacerbate systemic conditions like atherosclerosis, diabetes, obesity, and RA by disrupting macrophage function. Innovative metabolic treatments targeting these interactions could enhance the effectiveness of therapies in patients with refractory periodontitis and its related comorbidities.

Our sincere thanks go to the anonymous reviewers who provided valuable feedback on the first version of the manuscript.

The authors declare no conflicts of interest.

This research was supported by Grants from the Technical Project Task Book for Nanchong City to Zhen Liu (22SXQT0202).

Conception and design: Z.L. and Z.Z. Data collection: Z.Z. and Y.L. Drafting manuscript: Z.Z., Y.L., and T.Y. Revising manuscript content: Z.Z., Y.L., and Z.L. Approving final version of manuscript: Z.Z., Y.L., T.Y., and Z.L. Overall responsibility: Z.Z., Y.L., and Z.L.

Additional Information

Zihan Zhang and Yi Liu contributed equally to this work.

1.
Papapanou
PN
,
Sanz
M
,
Buduneli
N
,
Dietrich
T
,
Feres
M
,
Fine
DH
, et al
.
Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions
.
J Clin Periodontol
.
2018
;
45
(
Suppl 20
):
S162
70
.
2.
Petersen
PE
.
The World Oral Health Report 2003: continuous improvement of oral health in the 21st century – the approach of the WHO Global Oral Health Programme
.
Community Dent Oral Epidemiol
.
2003
;
31
(
Suppl 1
):
3
23
.
3.
Genco
RJ
,
Sanz
M
.
Clinical and public health implications of periodontal and systemic diseases: an overview
.
Periodontol
.
2020
;
83
(
1
):
7
13
.
4.
Potempa
J
,
Mydel
P
,
Koziel
J
.
The case for periodontitis in the pathogenesis of rheumatoid arthritis
.
Nat Rev Rheumatol
.
2017
;
13
(
10
):
606
20
.
5.
Hajishengallis
G
.
Periodontitis: from microbial immune subversion to systemic inflammation
.
Nat Rev Immunol
.
2015
;
15
(
1
):
30
44
.
6.
Acharya
C
,
Sahingur
SE
,
Bajaj
JS
.
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
.
JCI Insight
.
2017
;
2
(
19
):
e94416
.
7.
Schenkein
HA
,
Papapanou
PN
,
Genco
R
,
Sanz
M
.
Mechanisms underlying the association between periodontitis and atherosclerotic disease
.
Periodontol
.
2020
;
83
(
1
):
90
106
.
8.
Alvarez
C
,
Monasterio
G
,
Cavalla
F
,
Córdova
LA
,
Hernández
M
,
Heymann
D
, et al
.
Osteoimmunology of oral and maxillofacial diseases: translational applications based on biological mechanisms
.
Front Immunol
.
2019
;
10
:
1664
.
9.
Zhang
Z
,
Zhou
X
,
Liu
J
,
Zheng
Y
,
Wu
Y
,
Yang
W
, et al
.
d-mannose attenuates lipopolysaccharide-induced osteolysis via CPT1A-Mediated lipid metabolic regulation in macrophages
.
Biochem Biophys Res Commun
.
2021
;
583
:
135
41
.
10.
Cai
W
,
Cheng
J
,
Zong
S
,
Yu
Y
,
Wang
Y
,
Song
Y
, et al
.
The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner
.
Mol Immunol
.
2021
;
140
:
186
95
.
11.
Page
RC
,
Schroeder
HE
.
Pathogenesis of inflammatory periodontal disease. A summary of current work
.
Lab Invest
.
1976
;
34
(
3
):
235
49
.
12.
Yu
T
,
Gan
S
,
Zhu
Q
,
Dai
D
,
Li
N
,
Wang
H
, et al
.
Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24
.
Nat Commun
.
2019
;
10
(
1
):
4353
.
13.
Atri
C
,
Guerfali
F
,
Laouini
D
.
Role of human macrophage polarization in inflammation during infectious diseases
.
IJMS
.
2018
;
19
(
6
):
1801
.
14.
Funes
SC
,
Rios
M
,
Escobar-Vera
J
,
Kalergis
AM
.
Implications of macrophage polarization in autoimmunity
.
Immunology
.
2018
;
154
(
2
):
186
95
.
15.
Agrafioti
P
,
Morin-Baxter
J
,
Tanagala
KKK
,
Dubey
S
,
Sims
P
,
Lalla
E
, et al
.
Decoding the role of macrophages in periodontitis and type 2 diabetes using single-cell RNA-sequencing
.
FASEB J
.
2022
;
36
(
2
):
e22136
.
16.
Liu
J
,
Li
T
,
Zhang
S
,
Lu
E
,
Qiao
W
,
Chen
H
, et al
.
Proteomic and single-cell analysis shed new light on the anti-inflammatory role of interferonβ in chronic periodontitis
.
Front Pharmacol
.
2023
;
14
:
1232539
.
17.
Byles
V
,
Covarrubias
AJ
,
Ben-Sahra
I
,
Lamming
DW
,
Sabatini
DM
,
Manning
BD
, et al
.
The TSC-mTOR pathway regulates macrophage polarization
.
Nat Commun
.
2013
;
4
(
1
):
2834
.
18.
Halaby
MJ
,
McGaha
TL
.
Amino acid transport and metabolism in myeloid function
.
Front Immunol
.
2021
;
12
:
695238
.
19.
Yamaguchi
T
,
Movila
A
,
Kataoka
S
,
Wisitrasameewong
W
,
Ruiz Torruella
M
,
Murakoshi
M
, et al
.
Proinflammatory M1 macrophages inhibit RANKL-induced osteoclastogenesis
.
Infect Immun
.
2016
;
84
(
10
):
2802
12
.
20.
Shaddox
LM
,
Wiedey
J
,
Calderon
NL
,
Magnusson
I
,
Bimstein
E
,
Bidwell
JA
, et al
.
Local inflammatory markers and systemic endotoxin in aggressive periodontitis
.
J Dent Res
.
2011
;
90
(
9
):
1140
4
.
21.
Hienz
SA
,
Paliwal
S
,
Ivanovski
S
.
Mechanisms of bone resorption in periodontitis
.
J Immunol Res
.
2015
;
2015
:
615486
.
22.
Sun
X
,
Gao
J
,
Meng
X
,
Lu
X
,
Zhang
L
,
Chen
R
.
Polarized macrophages in periodontitis: characteristics, function, and molecular signaling
.
Front Immunol
.
2021
;
12
:
763334
.
23.
Wynn
TA
,
Vannella
KM
.
Macrophages in tissue repair, regeneration, and fibrosis
.
Immunity
.
2016
;
44
(
3
):
450
62
.
24.
Yu
T
,
Zhao
L
,
Huang
X
,
Ma
C
,
Wang
Y
,
Zhang
J
, et al
.
Enhanced activity of the macrophage M1/M2 phenotypes and phenotypic switch to M1 in periodontal infection
.
J Periodontol
.
2016
;
87
(
9
):
1092
102
.
25.
Zhao
Z
,
Ming
Y
,
Li
X
,
Tan
H
,
He
X
,
Yang
L
, et al
.
Hyperglycemia aggravates periodontitis via autophagy impairment and ROS-inflammasome-mediated macrophage pyroptosis
.
Int J Mol Sci
.
2023
;
24
(
7
):
6309
.
26.
Zhang
B
,
Yang
Y
,
Yi
J
,
Zhao
Z
,
Ye
R
.
Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis
.
J Periodontal Res
.
2021
;
56
(
5
):
991
1005
.
27.
Huynh
NC-N
,
Everts
V
,
Pavasant
P
,
Ampornaramveth
RS
.
Interleukin-1β induces human cementoblasts to support osteoclastogenesis
.
Int J Oral Sci
.
2017
;
9
(
12
):
e5
.
28.
Nakao
Y
,
Fukuda
T
,
Zhang
Q
,
Sanui
T
,
Shinjo
T
,
Kou
X
, et al
.
Exosomes from TNF-α-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss
.
Acta Biomater
.
2021
;
122
:
306
24
.
29.
Zhuang
Z
,
Yoshizawa-Smith
S
,
Glowacki
A
,
Maltos
K
,
Pacheco
C
,
Shehabeldin
M
, et al
.
Induction of M2 macrophages prevents bone loss in murine periodontitis models
.
J Dent Res
.
2019
;
98
(
2
):
200
8
.
30.
Chen
M-H
,
Wang
Y-H
,
Sun
B-J
,
Yu
L-M
,
Chen
Q-Q
,
Han
X-X
, et al
.
HIF-1α activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization
.
Int Immunopharmacol
.
2021
;
99
:
107901
.
31.
Yang
L
,
Tao
W
,
Xie
C
,
Chen
Q
,
Zhao
Y
,
Zhang
L
, et al
.
Interleukin-37 ameliorates periodontitis development by inhibiting NLRP3 inflammasome activation and modulating M1/M2 macrophage polarization
.
J Periodontal Res
.
2024
;
59
(
1
):
128
39
.
32.
Yang
J
,
Zhu
Y
,
Duan
D
,
Wang
P
,
Xin
Y
,
Bai
L
, et al
.
Enhanced activity of macrophage M1/M2 phenotypes in periodontitis
.
Arch Oral Biol
.
2018
;
96
:
234
42
.
33.
Papadopoulos
G
,
Weinberg
EO
,
Massari
P
,
Gibson
FC
3rd
,
Wetzler
LM
,
Morgan
EF
, et al
.
Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss
.
J Immunol
.
2013
;
190
(
3
):
1148
57
.
34.
Dalli
J
,
Serhan
CN
.
Pro-resolving mediators in regulating and conferring macrophage function
.
Front Immunol
.
2017
;
8
:
1400
.
35.
Balta
MG
,
Loos
BG
,
Nicu
EA
.
Emerging concepts in the resolution of periodontal inflammation: a role for resolvin E1
.
Front Immunol
.
2017
;
8
:
1682
.
36.
Ohira
T
,
Arita
M
,
Omori
K
,
Recchiuti
A
,
Van Dyke
TE
,
Serhan
CN
.
Resolvin E1 receptor activation signals phosphorylation and phagocytosis
.
J Biol Chem
.
2010
;
285
(
5
):
3451
61
.
37.
Kourtzelis
I
,
Li
X
,
Mitroulis
I
,
Grosser
D
,
Kajikawa
T
,
Wang
B
, et al
.
DEL-1 promotes macrophage efferocytosis and clearance of inflammation
.
Nat Immunol
.
2019
;
20
(
1
):
40
9
.
38.
Greenlee-Wacker
MC
.
Clearance of apoptotic neutrophils and resolution of inflammation
.
Immunol Rev
.
2016
;
273
(
1
):
357
70
.
39.
Li
B
,
Xin
Z
,
Gao
S
,
Li
Y
,
Guo
S
,
Fu
Y
, et al
.
SIRT6-regulated macrophage efferocytosis epigenetically controls inflammation resolution of diabetic periodontitis
.
Theranostics
.
2023
;
13
(
1
):
231
49
.
40.
Hajishengallis
G
,
Chavakis
T
.
DEL-1-Regulated immune plasticity and inflammatory disorders
.
Trends Mol Med
.
2019
;
25
(
5
):
444
59
.
41.
Inönü
E
,
Kayis
SA
,
Eskan
MA
,
Hakki
SS
.
Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease
.
J Periodontal Res
.
2020
;
55
(
4
):
511
8
.
42.
Derlindati
E
,
Dei Cas
A
,
Montanini
B
,
Spigoni
V
,
Curella
V
,
Aldigeri
R
, et al
.
Transcriptomic analysis of human polarized macrophages: more than one role of alternative activation
.
PLoS One
.
2015
;
10
(
3
):
e0119751
.
43.
Miao
Y
,
He
L
,
Qi
X
,
Lin
X
.
Injecting immunosuppressive M2 macrophages alleviates the symptoms of periodontitis in mice
.
Front Mol Biosci
.
2020
;
7
:
7603817
.
44.
Cavalla
F
,
Hernández
M
.
Polarization profiles of T lymphocytes and macrophages responses in periodontitis
.
Adv Exp Med Biol
.
2022
;
1373
:
195
208
.
45.
Medara
N
,
Lenzo
JC
,
Walsh
KA
,
Holden
JA
,
Reynolds
EC
,
Darby
IB
, et al
.
Peripheral memory T-cell profile is modified in patients undergoing periodontal management
.
J Clin Periodontol
.
2021
;
48
(
2
):
249
62
.
46.
Cavalla
F
,
Letra
A
,
Silva
RM
,
Garlet
GP
.
Determinants of periodontal/periapical lesion stability and progression
.
J Dent Res
.
2021
;
100
(
1
):
29
36
.
47.
Wang
L
,
Zhang
T
,
Zhang
Z
,
Wang
Z
,
Zhou
Y-J
,
Wang
Z
.
B cell activating factor regulates periodontitis development by suppressing inflammatory responses in macrophages
.
BMC Oral Health
.
2021
;
21
(
1
):
426
.
48.
Zouali
M
.
The emerging roles of B cells as partners and targets in periodontitis
.
Autoimmunity
.
2017
;
50
(
1
):
61
70
.
49.
Settem
RP
,
Honma
K
,
Chinthamani
S
,
Kawai
T
,
Sharma
A
.
B-cell RANKL contributes to pathogen-induced alveolar bone loss in an experimental periodontitis mouse model
.
Front Physiol
.
2021
;
12
:
722859
.
50.
Jung
J
,
Zeng
H
,
Horng
T
.
Metabolism as a guiding force for immunity
.
Nat Cell Biol
.
2019
;
21
(
1
):
85
93
.
51.
van Teijlingen Bakker
N
,
Pearce
EJ
.
Cell-intrinsic metabolic regulation of mononuclear phagocyte activation: findings from the tip of the iceberg
.
Immunol Rev
.
2020
;
295
(
1
):
54
67
.
52.
Van den Bossche
J
,
O’Neill
LA
,
Menon
D
.
Macrophage immunometabolism: where are we (going)
.
Trends Immunol
.
2017
;
38
(
6
):
395
406
.
53.
O’Neill
LA
,
Kishton
RJ
,
Rathmell
J
.
A guide to immunometabolism for immunologists
.
Nat Rev Immunol
.
2016
;
16
(
9
):
553
65
.
54.
Jha
AK
,
Huang
SC
,
Sergushichev
A
,
Lampropoulou
V
,
Ivanova
Y
,
Loginicheva
E
, et al
.
Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization
.
Immunity
.
2015
;
42
(
3
):
419
30
.
55.
Huang
SC
,
Everts
B
,
Ivanova
Y
,
O’Sullivan
D
,
Nascimento
M
,
Smith
AM
, et al
.
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
.
Nat Immunol
.
2014
;
15
(
9
):
846
55
.
56.
Vats
D
,
Mukundan
L
,
Odegaard
JI
,
Zhang
L
,
Smith
KL
,
Morel
CR
, et al
.
Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation
.
Cell Metab
.
2006
;
4
(
1
):
13
24
.
57.
Diskin
C
,
Pålsson-McDermott
EM
.
Metabolic modulation in macrophage effector function
.
Front Immunol
.
2018
;
9
:
270
.
58.
Yu
W
,
Wang
Z
,
Zhang
K
,
Chi
Z
,
Xu
T
,
Jiang
D
, et al
.
One-carbon metabolism supports S-adenosylmethionine and histone methylation to drive inflammatory macrophages
.
Mol Cell
.
2019
;
75
(
6
):
1147
60.e5
.
59.
Dolfi
B
,
Gallerand
A
,
Haschemi
A
,
Guinamard
RR
,
Ivanov
S
.
Macrophage metabolic regulation in atherosclerotic plaque
.
Atherosclerosis
.
2021
;
334
:
3341
8
.
60.
Liu
PS
,
Wang
H
,
Li
X
,
Chao
T
,
Teav
T
,
Christen
S
, et al
.
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming
.
Nat Immunol
.
2017
;
18
(
9
):
985
94
.
61.
Stirling
ER
,
Bronson
SM
,
Mackert
JD
,
Cook
KL
,
Triozzi
PL
,
Soto-Pantoja
DR
.
Metabolic implications of immune checkpoint proteins in cancer
.
Cells
.
2022
;
11
(
1
):
179
.
62.
Tannahill
GM
,
Curtis
AM
,
Adamik
J
,
Palsson-McDermott
EM
,
McGettrick
AF
,
Goel
G
, et al
.
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
.
Nature
.
2013
;
496
(
7444
):
238
42
.
63.
Huang
Y
,
Tian
C
,
Li
Q
,
Xu
Q
.
TET1 knockdown inhibits Porphyromonas gingivalis LPS/IFN-γ-induced M1 macrophage polarization through the NF-κB pathway in THP-1 cells
.
Int J Mol Sci
.
2019
;
20
(
8
):
2023
.
64.
He
Y
,
Wang
Y
,
Jia
X
,
Li
Y
,
Yang
Y
,
Pan
L
, et al
.
Glycolytic reprogramming controls periodontitis-associated macrophage pyroptosis via AMPK/SIRT1/NF-κB signaling pathway
.
Int Immunopharmacol
.
2023
;
119
:
110192
.
65.
Lin
J
,
Huang
D
,
Xu
H
,
Zhan
F
,
Tan
X
.
Macrophages: a communication network linking Porphyromonas gingivalis infection and associated systemic diseases
.
Front Immunol
.
2022
;
13
:
952040
.
66.
Hajishengallis
G
,
Wang
M
.
The importance of microbial community interactions in the pathogenesis of periodontitis
.
J Clin Periodontol
.
2017
;
44
(
8
):
944
5
.
67.
Fleetwood
AJ
,
Lee
MKS
,
Singleton
W
,
Achuthan
A
,
Lee
M-C
,
O’Brien-Simpson
NM
, et al
.
Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles
.
Front Cell Infect Microbiol
.
2017
;
7
:
351
.
68.
Cramer
T
,
Yamanishi
Y
,
Clausen
BE
,
Förster
I
,
Pawlinski
R
,
Mackman
N
, et al
.
HIF-1alpha is essential for myeloid cell-mediated inflammation
.
Cell
.
2003
;
112
(
5
):
645
57
.
69.
Van den Bossche
J
,
Baardman
J
,
de Winther
MP
.
Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis
.
J Vis Exp
.
2015
;(
105
):
53424
.
70.
Abdulkareem
AA
,
Al-Taweel
FB
,
Al-Sharqi
AJB
,
Gul
SS
,
Sha
A
,
Chapple
ILC
.
Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis
.
J Oral Microbiol
.
2023
;
15
(
1
):
2197779
.
71.
Guthmiller
JM
,
Novak
KF
.
Periodontal diseases
.
ASM Press
;
2002
.
72.
O’Neill
LA
,
Pearce
EJ
.
Immunometabolism governs dendritic cell and macrophage function
.
J Exp Med
.
2016
;
213
(
1
):
15
23
.
73.
Van den Bossche
J
,
Baardman
J
,
Otto
NA
,
van der Velden
S
,
Neele
AE
,
van den Berg
SM
, et al
.
Mitochondrial dysfunction prevents repolarization of inflammatory macrophages
.
Cell Rep
.
2016
;
17
(
3
):
684
96
.
74.
Grant
MM
.
Pyruvate kinase, inflammation and periodontal disease
.
Pathogens
.
2021
;
10
(
7
):
784
.
75.
Davis
IJ
,
Jones
AW
,
Creese
AJ
,
Staunton
R
,
Atwal
J
,
Chapple
IL
, et al
.
Longitudinal quantification of the gingival crevicular fluid proteome during progression from gingivitis to periodontitis in a canine model
.
J Clin Periodontol
.
2016
;
43
(
7
):
584
94
.
76.
Bostanci
N
,
Selevsek
N
,
Wolski
W
,
Grossmann
J
,
Bao
K
,
Wahlander
A
, et al
.
Targeted proteomics guided by label-free quantitative proteome analysis in saliva reveal transition signatures from health to periodontal disease
.
Mol Cell Proteomics
.
2018
;
17
(
7
):
1392
409
.
77.
Palsson-McDermott
EM
,
Curtis
AM
,
Goel
G
,
Lauterbach
MA
,
Sheedy
FJ
,
Gleeson
LE
, et al
.
Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages
.
Cell Metab
.
2015
;
21
(
1
):
65
80
.
78.
Shirai
T
,
Nazarewicz
RR
,
Wallis
BB
,
Yanes
RE
,
Watanabe
R
,
Hilhorst
M
, et al
.
The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease
.
J Exp Med
.
2016
;
213
(
3
):
337
54
.
79.
Yang
L
,
Xie
M
,
Yang
M
,
Yu
Y
,
Zhu
S
,
Hou
W
, et al
.
PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis
.
Nat Commun
.
2014
;
5
:
4436
.
80.
Song
Z
,
Xiaoli
AM
,
Yang
F
.
Regulation and metabolic significance of de novo lipogenesis in adipose tissues
.
Nutrients
.
2018
;
10
(
10
):
1383
.
81.
Batista-Gonzalez
A
,
Vidal
R
,
Criollo
A
,
Carreño
LJ
.
New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages
.
Front Immunol
.
2019
;
10
:
2993
.
82.
Odegaard
JI
,
Chawla
A
.
Alternative macrophage activation and metabolism
.
Annu Rev Pathol
.
2011
;
6
:
275
97
.
83.
Evans
AJ
,
Sawyez
CG
,
Wolfe
BM
,
Connelly
PW
,
Maguire
GF
,
Huff
MW
.
Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms
.
J Lipid Res
.
1993
;
34
(
5
):
703
17
.
84.
Chang
HR
,
Josefs
T
,
Scerbo
D
,
Gumaste
N
,
Hu
Y
,
Huggins
L-A
, et al
.
Role of LpL (lipoprotein lipase) in macrophage polarization in vitro and in vivo
.
Arterioscler Thromb Vasc Biol
.
2019
;
39
(
10
):
1967
85
.
85.
Zhu
L
,
Yang
T
,
Li
L
,
Sun
L
,
Hou
Y
,
Hu
X
, et al
.
TSC1 controls macrophage polarization to prevent inflammatory disease
.
Nat Commun
.
2014
;
5
:
4696
.
86.
Yan
J
,
Horng
T
.
Lipid metabolism in regulation of macrophage functions
.
Trends Cell Biol
.
2020
;
30
(
12
):
979
89
.
87.
Everts
B
,
Amiel
E
,
Huang
SC
,
Smith
AM
,
Chang
C-H
,
Lam
WY
, et al
.
TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation
.
Nat Immunol
.
2014
;
15
(
4
):
323
32
.
88.
Sakiyama
Y
,
Kato
R
,
Inoue
S
,
Suzuki
K
,
Itabe
H
,
Yamamoto
M
.
Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients
.
J Periodontal Res
.
2010
;
45
(
2
):
216
22
.
89.
Kunjathoor
VV
,
Febbraio
M
,
Podrez
EA
,
Moore
KJ
,
Andersson
L
,
Koehn
S
, et al
.
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages
.
J Biol Chem
.
2002
;
277
(
51
):
49982
8
.
90.
Nogieć
A
,
Bzowska
M
,
Demczuk
A
,
Varol
C
,
Guzik
K
.
Phenotype and response to PAMPs of human monocyte-derived foam cells obtained by long-term culture in the presence of oxLDLs
.
Front Immunol
.
2020
;
11
:
1592
.
91.
Ren
B
,
Van Kampen
E
,
Van Berkel
TJ
,
Cruickshank
SM
,
Van Eck
M
.
Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis
.
Atherosclerosis
.
2017
;
256
:
35
46
.
92.
Shynkevych
VI
,
Kolomiiets
SV
,
Kaidashev
IP
.
Effects of l-arginine and l-ornithine supplementations on the treatment of chronic periodontitis: a preliminary randomized short-term clinical trial
.
Heliyon
.
2021
;
7
(
11
):
e08353
.
93.
Prima
V
,
Wang
A
,
Molina
G
,
Wang
KK
,
Svetlov
SI
.
Inhibition of LPS toxicity by hepatic argininosuccinate synthase (ASS): novel roles for ASS in innate immune responses to bacterial infection
.
Int Immunopharmacol
.
2011
;
11
(
9
):
1180
8
.
94.
Biswas
SK
,
Lopez-Collazo
E
.
Endotoxin tolerance: new mechanisms, molecules and clinical significance
.
Trends Immunol
.
2009
;
30
(
10
):
475
87
.
95.
Wunderlich
CM
,
Ackermann
PJ
,
Ostermann
AL
,
Adams-Quack
P
,
Vogt
MC
,
Tran
M-L
, et al
.
Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment
.
Nat Commun
.
2018
;
9
(
1
):
1646
.
96.
Shin
KC
,
Hwang
I
,
Choe
SS
,
Park
J
,
Ji
Y
,
Kim
JI
, et al
.
Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation
.
Nat Commun
.
2017
;
8
(
1
):
1087
.
97.
Gerber
FA
,
Sahrmann
P
,
Schmidlin
OA
,
Heumann
C
,
Beer
JH
,
Schmidlin
PR
.
Influence of obesity on the outcome of non-surgical periodontal therapy: a systematic review
.
BMC Oral Health
.
2016
;
16
(
1
):
90
.
98.
Herz
MM
,
Hoffmann
N
,
Braun
S
,
Lachmann
S
,
Bartha
V
,
Petsos
H
.
Periodontal pockets: predictors for site-related worsening after non-surgical therapy – a long-term retrospective cohort study
.
J Clin Periodontol
.
2024
;
51
(
6
):
680
90
.
99.
Nishida
N
,
Tanaka
M
,
Hayashi
N
,
Nagata
H
,
Takeshita
T
,
Nakayama
K
, et al
.
Determination of smoking and obesity as periodontitis risks using the classification and regression tree method
.
J Periodontol
.
2005
;
76
(
6
):
923
8
.
100.
Li
Y
,
Lu
Z
,
Zhang
X
,
Yu
H
,
Kirkwood
KL
,
Lopes-Virella
MF
, et al
.
Metabolic syndrome exacerbates inflammation and bone loss in periodontitis
.
J Dent Res
.
2015
;
94
(
2
):
362
70
.
101.
Lu
Z
,
Li
Y
,
Brinson
CW
,
Kirkwood
KL
,
Lopes-Virella
MF
,
Huang
Y
.
CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate
.
Oral Dis
.
2017
;
23
(
2
):
210
8
.
102.
Amar
S
,
Zhou
Q
,
Shaik-Dasthagirisaheb
Y
,
Leeman
S
.
Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge
.
Proc Natl Acad Sci USA
.
2007
;
104
(
51
):
20466
71
.
103.
Jepsen
S
,
Caton
JG
,
Albandar
JM
,
Bissada
NF
,
Bouchard
P
,
Cortellini
P
, et al
.
Periodontal manifestations of systemic diseases and developmental and acquired conditions: consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions
.
J Clin Periodontol
.
2018
;
45
(
Suppl 20
):
S219
29
.
104.
Amar
S
,
Engelke
M
.
Periodontal innate immune mechanisms relevant to atherosclerosis
.
Mol Oral Microbiol
.
2015
;
30
(
3
):
171
85
.
105.
Hersoug
L-G
,
Møller
P
,
Loft
S
.
Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity
.
Nutr Res Rev
.
2018
;
31
(
2
):
153
63
.
106.
Trøseid
M
,
Nestvold
TK
,
Rudi
K
,
Thoresen
H
,
Nielsen
EW
,
Lappegård
KT
.
Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery
.
Diabetes Care
.
2013
;
36
(
11
):
3627
32
.
107.
Zhou
Q
,
Leeman
SE
,
Amar
S
.
Signaling mechanisms involved in altered function of macrophages from diet-induced obese mice affect immune responses
.
Proc Natl Acad Sci USA
.
2009
;
106
(
26
):
10740
5
.
108.
Zhou
Q
,
Leeman
SE
,
Amar
S
.
Signaling mechanisms in the restoration of impaired immune function due to diet-induced obesity
.
Proc Natl Acad Sci USA
.
2011
;
108
(
7
):
2867
72
.
109.
Richard
G
,
Trivedi
N
,
Belta
C
,
Amar
S
.
Partial restoration of macrophage alteration from diet-induced obesity in response to Porphyromonas gingivalis infection
.
PLoS One
.
2013
;
8
(
7
):
e70320
.
110.
Ham
M
,
Lee
J-W
,
Choi
AH
,
Jang
H
,
Choi
G
,
Park
J
, et al
.
Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress
.
Mol Cell Biol
.
2013
;
33
(
12
):
2425
35
.
111.
Appari
M
,
Channon
KM
,
McNeill
E
.
Metabolic regulation of adipose tissue macrophage function in obesity and diabetes
.
Antioxid Redox Signal
.
2018
;
29
(
3
):
297
312
.
112.
Moganti
K
,
Li
F
,
Schmuttermaier
C
,
Riemann
S
,
Klüter
H
,
Gratchev
A
, et al
.
Hyperglycemia induces mixed M1/M2 cytokine profile in primary human monocyte-derived macrophages
.
Immunobiology
.
2017
;
222
(
10
):
952
9
.
113.
Abais
JM
,
Xia
M
,
Zhang
Y
,
Boini
KM
,
Li
P-L
.
Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector
.
Antioxid Redox Signal
.
2015
;
22
(
13
):
1111
29
.
114.
Hung
S-L
,
Lee
N-G
,
Chang
L-Y
,
Chen
Y-T
,
Lai
Y-L
.
Stimulatory effects of glucose and Porphyromonas gingivalis lipopolysaccharide on the secretion of inflammatory mediators from human macrophages
.
J Periodontol
.
2014
;
85
(
1
):
140
9
.
115.
Ribeiro
FV
,
de Mendonça
AC
,
Santos
VR
,
Bastos
MF
,
Figueiredo
LC
,
Duarte
PM
.
Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis
.
J Periodontol
.
2011
;
82
(
8
):
1187
96
.
116.
Freemerman
AJ
,
Zhao
L
,
Pingili
AK
,
Teng
B
,
Cozzo
AJ
,
Fuller
AM
, et al
.
Myeloid Slc2a1-deficient murine model revealed macrophage activation and metabolic phenotype are fueled by GLUT1
.
J Immunol
.
2019
;
202
(
4
):
1265
86
.
117.
Nesbitt
MJ
,
Reynolds
MA
,
Shiau
H
,
Choe
K
,
Simonsick
EM
,
Ferrucci
L
.
Association of periodontitis and metabolic syndrome in the Baltimore Longitudinal Study of Aging
.
Aging Clin Exp Res
.
2010
;
22
(
3
):
238
42
.
118.
Mealey
BL
,
Oates
TW
;
American Academy of Periodontology
.
Diabetes mellitus and periodontal diseases
.
J Periodontol
.
2006
;
77
(
8
):
1289
303
.
119.
Hujoel
PP
,
Drangsholt
M
,
Spiekerman
C
,
DeRouen
TA
.
Periodontal disease and coronary heart disease risk
.
JAMA
.
2000
;
284
(
11
):
1406
10
.
120.
Lalla
E
,
Lamster
IB
,
Drury
S
,
Fu
C
,
Schmidt
AM
.
Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis
.
Periodontol
.
2000
;
23
:
2350
62
.
121.
Teles
R
,
Wang
C-Y
.
Mechanisms involved in the association between periodontal diseases and cardiovascular disease
.
Oral Dis
.
2011
;
17
(
5
):
450
61
.
122.
Hajishengallis
G
,
Chavakis
T
.
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
.
Nat Rev Immunol
.
2021
;
21
(
7
):
426
40
.
123.
Zaremba
M
,
Górska
R
,
Suwalski
P
,
Kowalski
J
.
Evaluation of the incidence of periodontitis-associated bacteria in the atherosclerotic plaque of coronary blood vessels
.
J Periodontol
.
2007
;
78
(
2
):
322
7
.
124.
Ford
PJ
,
Gemmell
E
,
Hamlet
SM
,
Hasan
A
,
Walker
PJ
,
West
MJ
, et al
.
Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis
.
Oral Microbiol Immunol
.
2005
;
20
(
5
):
296
302
.
125.
Ouimet
M
,
Barrett
TJ
,
Fisher
EA
.
HDL and reverse cholesterol transport
.
Circ Res
.
2019
;
124
(
10
):
1505
18
.
126.
Liu
F
,
Wang
Y
,
Xu
J
,
Liu
F
,
Hu
R
,
Deng
H
.
Effects of Porphyromonas gingivalis lipopolysaccharide on the expression of key genes involved in cholesterol metabolism in macrophages
.
Arch Med Sci
.
2016
;
12
(
5
):
959
67
.
127.
Shaik-Dasthagirisaheb
YB
,
Mekasha
S
,
He
X
,
Gibson
FC
3rd
,
Ingalls
RR
.
Signaling events in pathogen-induced macrophage foam cell formation
.
Pathog Dis
.
2016
;
74
(
6
):
ftw074
.
128.
Rho
JH
,
Kim
HJ
,
Joo
JY
,
Lee
JY
,
Lee
JH
,
Park
HR
.
Periodontal pathogens promote foam cell formation by blocking lipid efflux
.
J Dent Res
.
2021
;
100
(
12
):
1367
77
.
129.
Zhou
J
,
Liu
L
,
Wu
P
,
Zhao
L
,
Wu
Y
.
Fusobacterium nucleatum accelerates atherosclerosis via macrophage-driven aberrant proinflammatory response and lipid metabolism
.
Front Microbiol
.
2022
;
13
:
798685
.
130.
Shen
S
,
Sun
T
,
Ding
X
,
Gu
X
,
Wang
Y
,
Ma
X
, et al
.
The exoprotein Gbp of Fusobacterium nucleatum promotes THP-1 cell lipid deposition by binding to CypA and activating PI3K-AKT/MAPK/NF-κB pathways
.
J Adv Res
.
2024
;
57
:
93
105
.
131.
Nesse
W
,
Linde
A
,
Abbas
F
,
Spijkervet
FK
,
Dijkstra
PU
,
de Brabander
EC
, et al
.
Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics
.
J Clin Periodontol
.
2009
;
36
(
4
):
295
300
.
132.
Boord
JB
,
Maeda
K
,
Makowski
L
,
Babaev
VR
,
Fazio
S
,
Linton
MF
, et al
.
Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice
.
Circulation
.
2004
;
110
(
11
):
1492
8
.
133.
Furuhashi
M
,
Hotamisligil
GS
.
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
.
Nat Rev Drug Discov
.
2008
;
7
(
6
):
489
503
.
134.
Fu
Y
,
Luo
N
,
Lopes-Virella
MF
,
Garvey
WT
.
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages
.
Atherosclerosis
.
2002
;
165
(
2
):
259
69
.
135.
Djoussé
L
,
Gaziano
JM
.
Plasma levels of FABP4, but not FABP3, are associated with increased risk of diabetes
.
Lipids
.
2012
;
47
(
8
):
757
62
.
136.
Kim
DJ
,
Rho
JH
,
Woo
BH
,
Joo
JY
,
Lee
JY
,
Song
JM
, et al
.
Periodontal pathogens modulate lipid flux via fatty acid binding protein 4
.
J Dent Res
.
2019
;
98
(
13
):
1511
20
.
137.
Li
X
,
Tse
HF
,
Yiu
KH
,
Zhang
C
,
Jin
LJ
.
Periodontal therapy decreases serum levels of adipocyte fatty acid-binding protein in systemically healthy subjects: a pilot clinical trial
.
J Periodontal Res
.
2013
;
48
(
3
):
308
14
.
138.
Ma
X
,
Wang
Y
,
Wu
H
,
Li
F
,
Feng
X
,
Xie
Y
, et al
.
Periodontal health related-inflammatory and metabolic profiles of patients with end-stage renal disease: potential strategy for predictive, preventive, and personalized medicine
.
EPMA J
.
2021
;
12
(
2
):
117
28
.
139.
Lumeng
CN
.
Innate immune activation in obesity
.
Mol Aspects Med
.
2013
;
34
(
1
):
12
29
.
140.
Reilly
SM
,
Saltiel
AR
.
Adapting to obesity with adipose tissue inflammation
.
Nat Rev Endocrinol
.
2017
;
13
(
11
):
633
43
.
141.
Zhu
X
,
Tu
Y
,
Chen
H
,
Jackson
AO
,
Patel
V
,
Yin
K
.
Micro-environment and intracellular metabolism modulation of adipose tissue macrophage polarization in relation to chronic inflammatory diseases
.
Diabetes Metab Res Rev
.
2018
;
34
(
5
):
e2993
.
142.
Ambarus
CA
,
Noordenbos
T
,
de Hair
MJH
,
Tak
PP
,
Baeten
DLP
.
Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis
.
Arthritis Res Ther
.
2012
;
14
(
2
):
R74
.
143.
Yang
X
,
Chang
Y
,
Wei
W
.
Emerging role of targeting macrophages in rheumatoid arthritis: focus on polarization, metabolism and apoptosis
.
Cell Prolif
.
2020
;
53
(
7
):
e12854
.
144.
Soler Palacios
B
,
Estrada-Capetillo
L
,
Izquierdo
E
,
Criado
G
,
Nieto
C
,
Municio
C
, et al
.
Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile
.
J Pathol
.
2015
;
235
(
3
):
515
26
.
145.
Reichert
S
,
Haffner
M
,
Keyßer
G
,
Schäfer
C
,
Stein
JM
,
Schaller
H-G
, et al
.
Detection of oral bacterial DNA in synovial fluid
.
J Clin Periodontol
.
2013
;
40
(
6
):
591
8
.
146.
Rosenstein
ED
,
Greenwald
RA
,
Kushner
LJ
,
Weissmann
G
.
Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis
.
Inflammation
.
2004
;
28
(
6
):
311
8
.
147.
Ahmadi
P
,
Mahmoudi
M
,
Kheder
RK
,
Faraj
TA
,
Mollazadeh
S
,
Abdulabbas
HS
, et al
.
Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity
.
Int Immunopharmacol
.
2023
;
118
:
109936
.
148.
Peyssonnaux
C
,
Cejudo-Martin
P
,
Doedens
A
,
Zinkernagel
AS
,
Johnson
RS
,
Nizet
V
.
Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis
.
J Immunol
.
2007
;
178
(
12
):
7516
9
.
149.
Mills
EL
,
Kelly
B
,
Logan
A
,
Costa
ASH
,
Varma
M
,
Bryant
CE
, et al
.
Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages
.
Cell
.
2016
;
167
(
2
):
457
70.e13
.
150.
Noz
MP
,
Plachokova
AS
,
Smeets
EMM
,
Aarntzen
E
,
Bekkering
S
,
Vart
P
, et al
.
An explorative study on monocyte reprogramming in the context of periodontitis in vitro and in vivo
.
Front Immunol
.
2021
;
12
:
695227
.